Comparison of cisplatin-based combination chemotherapy with carboplatin-based combination chemotherapy in oral and pharyngeal cancers: an observatory pilot study
Journal Title: International Journal of Medical Science and Public Health - Year 2016, Vol 5, Issue 3
Abstract
Background: Oral and pharyngeal cancers are one of the most prevalent category of cancers worldwide. These kinds of cancers are associated with poor outcomes in terms of quality of life and mortality. The main modality of treatment is chemotherapy, and combination therapy based on cisplatin is commonly used. Cisplatin is associated with severe side effects, and there are some studies that revealed that carboplatin can be a good alternative to cisplatin. Objective: To compare cisplatin-based chemotherapy with carboplatin-based combination therapy in grades III and IV oral cancers. Materials and Methods: This is an observational study based on the patients of a tertiary-care center. The subjects were categorized into two groups based on the treatment regimen prescribed to them. Group I was administered intravenous (IV) paclitaxel (175 mg/m 2 ) and IV cisplatin (70 mg/m 2 ) on day 1 and IV 5-fluorouracil (FU; 1,200 mg/m 2 ) from days 2 to 4. This regimen was repeated after 21 days. A total of six cycles were completed. Group 2 was administered IV paclitaxel (175 mg/m 2 ) on day 1, IV carboplatin (dose calculated on AUC), and IV 5-FU (1,200 mg/m 2 ) from days 2 to 4. This regimen was repeated after 21 days, and such six such cycles were completed. Both the groups were compared for recovery and adverse effects after the completion of the study period. Result: There was no significant difference in recovery between both the groups ( p = 0.56, χ 2 = 1.12, df = 2). Adverse effects were more in the cisplatin group when compared with those in the carboplatin group. The most common adverse effects were nausea and vomiting, mucositis, and renal complications. Conclusion: There is no significant difference in efficacy between cisplatin and carboplatin, but carboplatin is safe when compared with cisplatin. Small sample size and observatory nature of the study are the serious limitations for interpreta - tion of these results.
Authors and Affiliations
Vibha Dhruw, Hemlata Thakur, Lakhan
Keywords
Related Articles
- EP ID EP112245
- DOI 10.5455/ijmsph.2016.0708201591
- Views 107
- Downloads 0
Perceptions of the community about epilepsy in rural Tamil Nadu, India
Background: There is no qualitative research on community’s perception about epilepsy available from India. However, some quantitative surveys were done among school children, local community, and patients of epilepsy. C...
An outbreak investigation of typhoid fever in Pondicherry, South India, 2013
Background: Preliminary investigation at Pediatric ward of Indira Gandhi Medical College revealed admission of a cluster of typhoid cases who were residents of one particular street in a nearby locality. Objectives:...
Knowledge, beliefs, and practices regarding malaria in urban setting of East Khasi Hills district, Meghalaya
Background: Malaria is still a leading public health problem in the northeastern regions of India. Besides mosquitogenic conditions in tribal areas, poor knowledge and attitude toward the disease is also one of the r...
The reliability and validity of Indian version of Chinese restaurant syndrome scale
Background: Universally people relish and appreciate attractive foods from the restaurants. Chinese restaurant syndrome (CRS) includes nexus web of symptoms such as numbness at the back of neck which is gradually radiati...
Perceptions and outlook towards HIV/AIDS among reproductive age group of urban slum population
Background: Acquired Immunodeficiency Disease Syndrome (AIDS) has evolved into a pandemic affecting millions of people worldwide. The global HIV/AIDS epidemic has had a major detrimental impact on high risk group...